Histamine N-methyltransferase modulates histamine- and antigen-induced bronchoconstriction in guinea pigs in vivo. 1993

K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
Department of Geriatric Medicine, Tohoku University School of Medicine, Sendai, Japan.

To examine whether histamine N-methyltransferase (HMT; EC 2.1.1.8) modulates the effects of allergic reaction in vivo, we studied the effects of aerosolized SKF 91488, a specific HMT inhibitor, on the responses to aerosolized histamine in unsensitized guinea pigs and to ovalbumin (OA) antigen inhalation in guinea pigs sensitized to OA. Airway responsiveness was assessed by determining provocation concentrations of histamine and OA aerosols that increased pulmonary resistance to twice the baseline values. SKF 94188 shifted, in a dose-dependent fashion, the dose-response curves to histamine and OA antigen to lower concentrations, and it significantly decreased provocation concentrations of both histamine and OA antigen (p < 0.01). In contrast of SKF 91488, aerosolized aminoguanidine, a specific inhibitor of diamine oxidase (10(-2) M, 90 breaths), did not alter the provocation concentration of histamine (p > 0.20). SKF 91488 (10(-2) M, 90 breaths) caused no significant changes in response to acetylcholine (p > 0.30). HMT activities were observed in the entire airways of the trachea, main bronchi, segmental bronchi and bronchioles, and parenchymal tissues. These findings suggest that HMT modulates the effects of exogenous histamine and endogenously released histamine by antigen challenge on bronchoconstrictor responses in guinea pigs in vivo.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008297 Male Males
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006637 Histamine N-Methyltransferase An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8. Histamine Methyltransferase,Histamine N Methyltransferase,Methyltransferase, Histamine,N-Methyltransferase, Histamine
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
October 1990, The Journal of allergy and clinical immunology,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
February 2002, European journal of pharmacology,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
March 2003, Life sciences,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
October 1984, Agents and actions,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
May 1989, Journal of applied physiology (Bethesda, Md. : 1985),
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
December 2005, Collegium antropologicum,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
July 1992, The American review of respiratory disease,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
November 1991, The European respiratory journal,
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
March 1989, Journal of applied physiology (Bethesda, Md. : 1985),
K Sekizawa, and H Nakazawa, and T Ohrui, and K Yamauchi, and Y Ohkawara, and K Maeyama, and T Watanabe, and H Sasaki, and T Takishima
April 1990, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!